OrthoPediatrics KIDS Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net revenue by Product | ||||||
| Scoliosis | $15.44M-12.3% | $17.6M+8.2% | $16.26M-12.2% | $18.52M+35.6% | $13.66M-12.6% | |
| Sports medicine/other | $875K-36.1% | $1.37M+61.8% | $846K-6.5% | $905K+2.8% | $880K+41.0% | |
| Trauma and deformity | $43.05M+1.0% | $42.64M-3.4% | $44.14M+6.0% | $41.66M+10.0% | $37.87M+4.0% | |
| Net revenue by Geography | ||||||
| International | $14.05M+8.4% | $12.96M+3.4% | $12.53M-3.1% | $12.94M+12.3% | $11.52M+17.9% | |
| U.S. | $45.31M-6.9% | $48.65M-0.1% | $48.72M+1.2% | $48.15M+17.7% | $40.89M-4.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does OrthoPediatrics break its business down?
- OrthoPediatrics (KIDS) reports net revenue by product across 3 parts — Scoliosis, Sports medicine/other and Trauma and deformity. Each is extracted from the segment footnotes and tracked over time.
- Where does OrthoPediatrics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in OrthoPediatrics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
